Author Archive

Advocates Strategize on Pain Care Policy at GAfPA’s Malta Workshop

Young King David beat the biblical giant Goliath, as advocates at a Global Alliance for Patient Access workshop in Malta were recently reminded. In the

Read More

EU Group Calls for Greater Transparency in Labelling Biosimilars

EU regulators who want to encourage understanding and acceptance of biosimilar medicines might consider improving the drugs’ labels.  So says the stakeholders group EuropaBio, which

Read More

STATEMENT FROM ALLIANCE FOR PATIENT ACCESS ON DRUG IMPORTATION AMENDMENT

Physician organization urges lawmakers to prioritize access to safe, approved medications WASHINGTON (June 7, 2017) – The Alliance for Patient Access (AfPA) made the following

Read More

Research on Preventive Drugs Raises Hopes in the Migraine Community

For chronic migraine patients, the only thing better than making a headache stop is preventing it altogether.  And new research suggests that patients may soon

Read More

***PRESS RELEASE*** Mississippi Health Plans Reject More than Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations; BCBS Mississippi rejected 100 percent of claims  WASHINGTON – The Institute for

Read More

Patient Advocates Line Up Behind Federal Step Therapy Bill

A congressional effort to improve patients’ access to treatment is generating widespread enthusiasm in the advocacy community.  Sponsored by Rep. Brad Wenstrup, DPM, (R-Ohio) and

Read More

Cystic Fibrosis Group Defines Barriers to Treatment Access

Orphan drugs aren’t always reaching the patients who need them, and an advocacy group known as the Cystic Fibrosis Engagement Network has a few ideas

Read More

Drug Approval Signals New Era in Cancer Care

Is precision medicine gaining traction in the field of oncology?  The Food and Drug Administration’s recent approval of the cancer drug pembrolizumab offers a hint. 

Read More

High Out-of-Pocket Costs Threaten Access for Medicare Patients

Some Medicare beneficiaries pay 20 percent of their income in out-of-pocket medical expenses, a new study finds.  And a disproportionate number of those are low-income

Read More

The New Face of Hepatitis C

Long considered an affliction of the baby boomer generation, hepatitis C now has spiked among a surprising new population: young people. Hepatitis C infections hit

Read More
Back to Top